Infectious Diseases 1212 - Infectious Disease Alert - Dec 01, 2008

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editors
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Frank J. Bia, MD, MPH
Professor of Geographic and Laboratory Medicine
Co-Director, Tropical Medicine and International Travelers' Clinc
Yale University School of Medicine

Board Member and Peer Reviewers
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Philip R. Fischer, MD, DTM&H
Professor of Pediatrics
Department of Pediatrics and Adolescent Medicine
Mayo Clinic
Rochester, MN.

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editor
Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor, Stanford University School of Medicine

Authors
Mary-Louise Scully, MD
Director, Travel and Tropical Medicine Center
Sansum Clinic
Santa Barbara, CA.

Maria D. Mileno, MD
Director, Travel Medicine
The Miriam Hospital
Associate Professor of Medicine
Brown University, Providence, RI.

Michele Barry, MD, FACP
Professor of Medicine
Co-Director, International Health Program
Department of International Medicine
Yale University School of Medicine
New Haven, CT

Subjects:

  • XDR-TB in the United States
  • Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-cell Transplantation
  • Quality Improvement Interventions and Surgical Antimicrobial Prophylaxis
  • Altitude Sickness and Adventure Travel
  • 2008 Prevention of Influenza Guidelines: Changes to Consider
  • Travelers and Eosinophilia
  • Pneumonic Tularemia in Brooklyn, New York
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • present current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker's bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Travel Medicine Advisor’s Physician Editor, Frank J. Bia, MD, MPH is a consultant for Pfizer and Sanofi Pasteur, and receives funds from Johnson & Johnson

Peer Reviewers Connie Price, MD, and Philip R. Fischer, MD, DTM&H, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study.

Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for Boehringer-Ingelheim and GSK.

Updates author Carol A. Kemper, MD, FACP, Authors Mary-Louise Scully, MD, Maria D. Mileno, MD, and Michele Barry, MD, FACP, report no financial relationships relevant to this field of study.

Copyright 2008 AHC Media. All rights reserved.